Skip to main content

Accelerate Diagnostics, Inc

AXDXDelisted Jul 21, 2025
Industry
Laboratory Analytical Instruments
SEC CIK
0000727207

Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Accelerate Diagnostics, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Accelerate Diagnostics, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Accelerate Diagnostics, Inc
NameTitleLast reported holdingLast filingFilings, past year
Phillips JackChief Executive Officer191,374Apr 7, 20250
Mertz Larry MichaelChief Technology Officer84,803Apr 7, 20250
Patience DavidChief Financial Officer64,568Apr 2, 20250
Schuler Jack WDirector, 10% Owner8,310,388IndirectDec 3, 20240
Patience JohnDirector653,224IndirectDec 3, 20240
Massarany HanyDirector36,891Jul 1, 20240
Francesconi LouiseDirector33,558Jul 1, 20240
Burris WayneDirector1,678Jun 3, 20240
Regan JenniferDirector12,631May 30, 20240
Ogilvie Marran H.Director–May 21, 20240
Black Mark S.Director–May 21, 20240
Strobeck MatthewDirector120,682IndirectJan 25, 20240
Brown Thomas DDirector116,160May 26, 20230
Watts Charles MDirector69,619May 26, 20230
Reichling StevenChief Financial Officer142,370Mar 15, 20230
Miller Mark CDirector55,282Mar 9, 20230
Ten Brink Frank JMDirector60,686Mar 6, 20230
Price RonHead of Commercial Operations40,610Apr 25, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 7, 2025 (view filing)Apr 43 daysPhillips JackChief Executive OfficerSSale−25.3K$0.65−$16.5K−11.7%191.4K after
Apr 7, 2025 (view filing)Apr 43 daysMertz Larry MichaelChief Technology OfficerSSale−1.52K$0.65−$989.95−1.8%84.8K after
Apr 2, 2025 (view filing)Apr 11 dayPatience DavidChief Financial OfficerSSale−6.82K$0.71−$4.84K−9.5%64.6K after
Feb 27, 2025 (view filing)Feb 261 dayPatience DavidChief Financial OfficerSSale−535$1.09−$583.15−1.0%51.4K after
Feb 4, 2025 (view filing)Feb 31 dayPhillips JackChief Executive OfficerSSale−485$1.35−$654.75−0.3%163.4K after
Dec 3, 2024 (view filing)Dec 3Same dayPatience JohnDirectorPPurchase+200.0K$1.57+$314.0K+44.1%653.2K after
Dec 3, 2024 (view filing)Dec 3Same daySchuler Jack WDirector, 10% OwnerSSale−200.0K$1.57−$314.0K−2.4%8.31M after
May 21, 2024 (view filing)May 201 dayMertz Larry MichaelChief Technology OfficerSSale−361$0.88−$317.68−0.4%82.0K after2 lots
Apr 18, 2024 (view filing)Apr 171 dayPhillips JackChief Executive OfficerSSale−26.7K$0.78−$20.9K−14.1%162.9K after10b5-1
Apr 16, 2024 (view filing)Apr 124 daysPhillips JackChief Executive OfficerSSale−26.5K$0.86−$22.8K−17.0%129.7K after10b5-1
Apr 10, 2024 (view filing)Apr 91 dayPatience DavidChief Financial OfficerSSale−13.3K$0.87−$11.6K−20.9%50.4K after
Apr 10, 2024 (view filing)Apr 91 dayMertz Larry MichaelChief Technology OfficerSSale−14.0K$0.87−$12.2K−14.7%81.1K after
Apr 5, 2024 (view filing)Apr 41 dayMertz Larry MichaelChief Technology OfficerSSale−978$0.88−$860.64−1.8%54.5K after
Apr 5, 2024 (view filing)Apr 41 dayPhillips JackChief Executive OfficerSSale−15.9K$0.88−$14.0K−14.2%96.3K after
Feb 27, 2024 (view filing)Feb 261 dayPatience DavidChief Financial OfficerSSale−350$0.96−$336−1.3%26.2K after
Feb 2, 2024 (view filing)Feb 11 dayPhillips JackChief Executive OfficerSSale−494$1.30−$642.2−0.6%76.7K after
Jan 25, 2024 (view filing)Jan 232 daysStrobeck MatthewDirectorPPurchase+100.0K––+483.5%120.7K after
Jan 25, 2024 (view filing)Jan 232 daysStrobeck MatthewDirectorPPurchase+100.0K–––100.0K afterDerivative
Jan 25, 2024 (view filing)Jan 232 daysFrancesconi LouiseDirectorPPurchase+13.3K––+175.6%20.9K after
Jan 25, 2024 (view filing)Jan 232 daysFrancesconi LouiseDirectorPPurchase+13.3K–––13.3K afterDerivative
Jan 25, 2024 (view filing)Jan 232 daysMassarany HanyDirectorPPurchase+16.7K––+219.5%24.3K after
Jan 25, 2024 (view filing)Jan 232 daysMassarany HanyDirectorPPurchase+16.7K–––16.7K afterDerivativeDuplicate filing
Jan 25, 2024 (view filing)Jan 232 daysPatience JohnDirectorPPurchase+16.7K––+3.8%453.2K after
Jan 25, 2024 (view filing)Jan 232 daysPatience JohnDirectorPPurchase+16.7K–––16.7K afterDerivative
Dec 14, 2023 (view filing)Dec 131 dayPhillips JackChief Executive OfficerSSale−739$4.39−$3.24K−1.2%59.5K after
Dec 14, 2023 (view filing)Dec 131 dayPatience DavidChief Financial OfficerSSale−97$4.39−$425.83−1.1%8.93K after
Nov 14, 2023 (view filing)Nov 131 dayPhillips JackChief Executive OfficerSSale−745$5.58−$4.16K−1.3%58.6K after
Nov 14, 2023 (view filing)Nov 131 dayPatience DavidChief Financial OfficerSSale−97$5.57−$540.29−1.1%8.70K after
Oct 16, 2023 (view filing)Oct 133 daysPatience DavidChief Financial OfficerSSale−96$5.83−$559.68−1.1%8.46K after
Oct 16, 2023 (view filing)Oct 133 daysPhillips JackChief Executive OfficerSSale−734$5.83−$4.28K−1.3%57.6K after
Sep 14, 2023 (view filing)Sep 131 dayPhillips JackChief Executive OfficerSSale−733$6.53−$4.79K−1.3%56.6K after
Sep 14, 2023 (view filing)Sep 131 dayPatience DavidChief Financial OfficerSSale−96$6.53−$626.88−1.2%8.23K after
Aug 15, 2023 (view filing)Aug 141 dayPhillips JackChief Executive OfficerSSale−751$6.80−$5.11K−1.3%55.6K after
Aug 15, 2023 (view filing)Aug 141 dayPatience DavidChief Financial OfficerSSale−95$6.80−$646−1.2%7.99K after
Jul 17, 2023 (view filing)Jul 134 daysPatience DavidChief Financial OfficerSSale−92$6.90−$634.8−1.2%7.76K after
Jul 17, 2023 (view filing)Jul 134 daysPhillips JackChief Executive OfficerSSale−729$6.90−$5.03K−1.3%54.6K after
Jun 26, 2023 (view filing)Jun 224 daysPhillips JackChief Executive OfficerSSale−27.3K$0.71−$19.4K−4.8%536.4K afterFrom original
Jun 15, 2023 (view filing)Jun 132 daysPatience DavidChief Financial OfficerSSale−1.29K$0.90−$1.16K−1.7%75.2K after
Jun 15, 2023 (view filing)Jun 132 daysPhillips JackChief Executive OfficerSSale−8.39K$0.90−$7.55K−1.6%501.5K after
May 24, 2023 (view filing)May 222 daysMertz Larry MichaelChief Technology OfficerSSale−3.48K$0.72−$2.51K−0.7%525.7K after2 lots
May 16, 2023 (view filing)May 151 dayPhillips JackChief Executive OfficerSSale−7.94K$0.69−$5.48K−1.6%492.6K after
May 16, 2023 (view filing)May 151 dayPatience DavidChief Financial OfficerSSale−1.22K$0.69−$843.18−1.6%73.2K after
Apr 17, 2023 (view filing)Apr 134 daysPatience DavidChief Financial OfficerSSale−1.15K$0.65−$745.55−1.6%71.1K after
Apr 17, 2023 (view filing)Apr 134 daysPhillips JackChief Executive OfficerSSale−7.44K$0.65−$4.84K−1.5%483.4K after
Mar 15, 2023 (view filing)2:15 PM ETMar 132 daysReichling StevenChief Financial OfficerSSale−4.71K$0.49−$2.31K−3.2%142.4K after
Mar 15, 2023 (view filing)2:15 PM ETMar 132 daysPhillips JackChief Executive OfficerSSale−7.45K$0.49−$3.65K−1.5%473.6K after
Mar 13, 2023 (view filing)5:46 PM ETMar 85 daysLateReichling StevenChief Financial OfficerSSale−62.8K$0.47−$29.5K−31.3%137.6K after
Mar 13, 2023 (view filing)5:46 PM ETMar 85 daysLatePhillips JackChief Executive OfficerSSale−155.6K$0.47−$73.1K−25.1%463.8K after
Mar 6, 2023 (view filing)7:41 PM ETMar 24 daysMertz Larry MichaelChief Technology OfficerSSale−33.4K$0.49−$16.4K−6.1%516.3K after
Feb 15, 2023 (view filing)Feb 132 daysReichling StevenChief Financial OfficerSSale−4.82K$0.60−$2.89K−5.9%76.8K after